SUSAN ANDERSON: Open Payments
NPI 1891726709 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,718 in 94 payments from 25 companies in 2025. Trend: 2023 $1,806 · 2024 $1,838 · 2025 $4,718
Consulting: $2,500Food & beverage: $1,684Travel & lodging: $450Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $3,121 |
| Mannkind Corporation | 10 | $232 |
| Amgen Inc. | 14 | $211 |
| Novo Nordisk Inc | 10 | $168 |
| Corcept Therapeutics | 7 | $136 |
| BETA BIONICS, INC. | 1 | $116 |
| Axsome Therapeutics, Inc. | 4 | $93 |
| Astellas Pharma US Inc | 5 | $88 |
| Lundbeck LLC | 3 | $69 |
| Sequel Med Tech, LLC | 3 | $67 |
Products named: MOUNJARO, AFREZZA, OTEZLA, Korlym, iLet Bionic Pancreas, Wegovy, Veozah, Symbravo.
Industry payments across TN — which companies pay providers there.
